Hypoxia-Inducible Expression of Annexin A6 Enhances the Resistance of Triple-Negative Breast Cancer Cells to EGFR and AR Antagonists is a research paper published in Cells (2022). On theSindex it has a DataRank of 0. It has been cited 15 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
MMC-VICC-TSU Cancer Partnership
Grant: NIH/NIGMS SC1 CA211030
MMC-VICC-TSU Cancer Partnership
Grant: U54 CA163069
MMC-VICC-TSU Cancer Partnership
Grant: U54 MD007586
MMC-VICC-TSU Cancer Partnership
Grant: P50CA098131
NIGMS NIH HHS
Grant: R25 GM059994
NCI NIH HHS
Grant: SC1 CA211030
National Institutes of Health
Grant: 3U54MD007586-34S3
The RCMI Program in Health Disparities Research at Meharry Medical College (Supplement)
National Institutes of Health
Grant: 3P50CA098131-15S1
SPORE in Breast Cancer
National Institutes of Health
Grant: 5U54CA163069-05
Development: Cancer Outreach Core
National Institutes of Health
Grant: 5R25GM059994-16
RISE Option III The Meharry RISE Initiative
National Institutes of Health
Grant: 5SC1CA211030-02
MECHANISMS OF ANNEXIN A6-MEDIATED BASAL-LIKE BREAST CANCER PROGRESSION
FWCI
1.02
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals